You are here: Industry Insights > Pfizer

News List

Working through CEO swap, Pfizer plots job cuts in drive for 'simpler' structure fiercepharma
October 19, 2018
A week after Pfizer unveiled a reshuffled executive team that'll report to incoming CEO Albert Bourla, the company said it's restructuring to simplify management and boost efficiency. And this latest move means job ...
FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients pharmafile
October 19, 2018
Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to hit the market in the US...
Pfizer announce cull of 2% of staff pharmafile
October 19, 2018
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year.
Pfizer announces Executive Leadership Team worldpharmanews
October 12, 2018
Pfizer Inc. (NYSE:PFE) today announced its executive team that will report to Albert Bourla, incoming Chief Executive Officer, coincident with the commencement of his new role effective January 1, 2019.
Pfizer's Innovative drug IBRANCE gets China approval .biospectrumasia
October 11, 2018
World's First Kinase 4/6 (CDK 4/6) Inhibitor and Only Innovative Breakthrough Therapy for Advanced Breast Cancer in China over Past Ten Years
Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts fiercepharma
October 11, 2018
China is quickly approving many of the newest cancer drugs but it also is demanding big discounts if drugmakers want them on its national insurance coverage list.
Celebrating sales and marketing excellence pharmatimes
October 11, 2018
Such is the link between the two disciplines, Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside the all-new Sales Awards.
Pfizer Names New CEO contractpharma
October 08, 2018
Albert Bourla to succeed Ian Read
Pfizer's once-failed Vizimpro rebounds with targeted lung cancer approval fiercepharma
September 29, 2018
After flunking two late-stage trials in 2014, Pfizer's Vizimpro won an FDA green light Thursday.
US green light for Pfizer’s lung cancer drug pharmatimes
September 29, 2018
Pfizer’s pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor dacomitinib has been approved in the US as a treatment for some forms of lung cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page